NasdaqCM - Nasdaq Real Time Price USD

UFP Technologies, Inc. (UFPT)

206.80

-0.09

(-0.04%)

At close: April 25 at 4:00:01 PM EDT

206.80

0.00

(0.00%)

After hours: April 25 at 4:05:14 PM EDT

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

A number of stocks fell in the afternoon session after stocks gave back some of the gains from the previous day as the White House clarified the tariffs on imports from China would add up to 145%, while the baseline 10% tariffs remained in place for most countries. This reminded investors that the global trade environment remained volatile, limiting the potential for sustained market gains.

StockStory 17 days ago

HAE

UFPT
-0.04%
TFX
Should You Think About Buying UFP Technologies, Inc. (NASDAQ:UFPT) Now?

UFP Technologies, Inc. ( NASDAQ:UFPT ), might not be a large cap stock, but it saw a decent share price growth of 13...

Simply Wall St. 17 days ago

UFPT
-0.04%
Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how IQVIA (NYSE:IQV) and the rest of the drug development inputs & services stocks fared in Q4.

StockStory last month

IQV

UFPT
-0.04%
RGEN
Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at West Pharmaceutical Services (NYSE:WST) and its peers.

StockStory last month

WST

UFPT
-0.04%
IQV
1 Healthcare Stock on Our Watchlist and 2 to Brush Off

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 9.1%. This drop was worse than the S&P 500’s 1.8% loss.

StockStory last month

INCY

UFPT
-0.04%
UFP Technologies to Present and Host Investor Meetings at the KeyBanc Capital Healthcare Forum

NEWBURYPORT, Mass., March 17, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an Innovative designer and custom manufacturer of components, subassemblies, products, and packaging primarily for the medical market, today announced that Chairman and Chief Executive Officer R. Jeffrey Bailly and Chief Financial Officer Ron Lataille will participate in the upcoming KeyBanc Capital Markets Healthcare Forum to be held virtually on March 18, 2025. UFP’s presentation is scheduled to begin

GlobeNewswire last month

UFPT
-0.04%
Is UFP Technologies, Inc. (NASDAQ:UFPT) Trading At A 48% Discount?

Key Insights Using the 2 Stage Free Cash Flow to Equity, UFP Technologies fair value estimate is US$400 Current share...

Simply Wall St. last month

UFPT
-0.04%
Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at drug development inputs & services stocks, starting with UFP Technologies (NASDAQ:UFPT).

StockStory last month

UFPT
-0.04%
3 Small-Cap Stocks in Hot Water

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.

StockStory last month

EAT

RMAX

UFPT
-0.04%
3 Small-Cap Stocks Walking a Fine Line

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.

StockStory last month

QLYS

UFPT
-0.04%
PRLB
Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Azenta (NASDAQ:AZTA) and its peers.

StockStory last month

UFPT
-0.04%
RGEN
What To Expect From Fortrea’s (FTRE) Q4 Earnings

Clinical research company Fortrea Holdings (NASDAQ:FTRE) will be reporting earnings tomorrow before market hours. Here’s what investors should know.

StockStory last month

UFPT
-0.04%
UFP Technologies, Inc. (NASDAQ:UFPT) Full-Year Results: Here's What Analysts Are Forecasting For This Year

It's been a sad week for UFP Technologies, Inc. ( NASDAQ:UFPT ), who've watched their investment drop 13% to US$232 in...

Simply Wall St. last month

UFPT
-0.04%
UFP Technologies Full Year 2024 Earnings: EPS Beats Expectations

UFP Technologies ( NASDAQ:UFPT ) Full Year 2024 Results Key Financial Results Revenue: US$504.4m (up 26% from FY 2023...

Simply Wall St. last month

UFPT
-0.04%
Why UFP Technologies (UFPT) Stock Is Trading Up Today

Shares of medical products company UFP Technologies (NASDAQ:UFPT) jumped 9.9% in the afternoon session after the company delivered an encouraging quarter, surpassing analysts' expectations for revenue, EPS, and EBITDA. Sales surged 41.9% y/y, driven by strong performance in the MedTech segment, which grew 48.6%, while other markets saw a modest decline. Profitability improved as gross margins expanded to 29.2%, helping the company deliver the earnings beat.

StockStory last month

UFPT
-0.04%
UFP Technologies (NASDAQ:UFPT) Exceeds Q4 Expectations

Medical products company UFP Technologies (NASDAQ:UFPT) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 41.9% year on year to $144.1 million. Its GAAP profit of $2.10 per share was 5.9% above analysts’ consensus estimates.

StockStory last month

UFPT
-0.04%
UFP: Q4 Earnings Snapshot

NEWBURYPORT, Mass. AP) — UFP Technologies Inc. UFPT) on Tuesday reported net income of $16.4 million in its fourth quarter.

Associated Press Finance last month

UFPT
-0.04%
UFP Technologies Announces Record 2024 Results

NEWBURYPORT, Mass., Feb. 25, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a designer and custom manufacturer of engineered solutions primarily for the medical market, today reported 2024 net income of $59.0 million, 31.3% higher than net income of $44.9 million for 2023. Adjusted net income grew 32.5% to $67.6 million. Net sales for 2024 were $504.4 million, 26.1% higher than 2023 sales of $400.1 million. GAAP and adjusted earnings per diluted common share outstanding (EPS) we

GlobeNewswire last month

UFPT
-0.04%
UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings

Medical products company UFP Technologies (NASDAQ:UFPT) will be announcing earnings results tomorrow morning. Here’s what to look for.

StockStory 2 months ago

UFPT
-0.04%
CRL
UFP Technologies to Report Fourth Quarter and Year-end 2024 Results on February 25, 2025

NEWBURYPORT, Mass., Feb. 19, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), an innovative designer and custom manufacturer of comprehensive solutions for medical devices, sterile packaging and other highly engineered custom products, today announced that the Company plans to report results for the fourth quarter and year-ended December 31, 2024, on Tuesday, February 25th. About UFP Technologies, Inc. UFP Technologies is an innovative designer and custom manufacturer of comprehen

GlobeNewswire 2 months ago

UFPT
-0.04%

Performance Overview

Return	UFPT	S&P 500 (^GSPC)
YTD	-15.42%	-6.06%
1-Year	-1.36%	+9.44%
3-Year	+189.31%	+28.61%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

UFP Technologies, Inc. (UFPT)

BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know

Should You Think About Buying UFP Technologies, Inc. (NASDAQ:UFPT) Now?

Winners And Losers Of Q4: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks

Unpacking Q4 Earnings: West Pharmaceutical Services (NYSE:WST) In The Context Of Other Drug Development Inputs & Services Stocks

1 Healthcare Stock on Our Watchlist and 2 to Brush Off

UFP Technologies to Present and Host Investor Meetings at the KeyBanc Capital Healthcare Forum

Is UFP Technologies, Inc. (NASDAQ:UFPT) Trading At A 48% Discount?

Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks

3 Small-Cap Stocks in Hot Water

3 Small-Cap Stocks Walking a Fine Line

Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks

What To Expect From Fortrea’s (FTRE) Q4 Earnings

UFP Technologies, Inc. (NASDAQ:UFPT) Full-Year Results: Here's What Analysts Are Forecasting For This Year

UFP Technologies Full Year 2024 Earnings: EPS Beats Expectations

Why UFP Technologies (UFPT) Stock Is Trading Up Today

UFP Technologies (NASDAQ:UFPT) Exceeds Q4 Expectations

UFP: Q4 Earnings Snapshot

UFP Technologies Announces Record 2024 Results

UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings

UFP Technologies to Report Fourth Quarter and Year-end 2024 Results on February 25, 2025

Performance Overview